Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

BPC-157 Reconstitution: Step-by-Step Guide

When you buy from a trusted website, BPC-157 is usually supplied as a lyophilised powder. In simple terms, this means the peptide has been freeze-dried so it can remain more stable before laboratory preparation. Before it can be used in a research protocol, th

When you buy from a trusted website, BPC-157 is usually supplied as a lyophilised powder.

In simple terms, this means the peptide has been freeze-dried so it can remain more stable before laboratory preparation.

Before it can be used in a research protocol, the powder normally needs to be reconstituted with a suitable sterile liquid. The aim is to create a clear, evenly mixed solution with a known concentration.

This guide explains how BPC-157 reconstitution works in a research-only setting.

It covers what you need, how to choose the right liquid, how to calculate concentration, how to mix the vial correctly, and what to check before storing the prepared solution.

What You Need

Before starting, prepare everything in advance. This keeps the process clean, consistent, and easier to control.

Essential items

BPC-157 lyophilised vial

Bacteriostatic water (BAC water) and not sterile water (explained below)

Sterile measuring syringe or calibrated micropipette

Alcohol swabs

Clean gloves

Sharps-safe disposal container, where applicable

Permanent marker or vial label

Clean, flat workspace

Why BPC-157 Reconstitution Matters

Reconstitution is not just “adding water”. It affects concentration accuracy, solution clarity, storage stability, and repeatability in research work.

If too much liquid is added, the final solution becomes weaker than intended. If too little is added, the solution becomes more concentrated and harder to measure accurately.

Whereas, if the liquid is added too forcefully, the peptide cake may foam, cling to the vial, or dissolve unevenly.

Good reconstitution should produce a solution that is:

Clear or nearly clear

Free from visible particles

Correctly labelled

Stored under suitable conditions

Easy to calculate for research measurements

The main goal is consistency. Every future measurement depends on the concentration created during this step.

Bacteriostatic Water vs Sterile Water

For many research peptide preparations, bacteriostatic water is commonly selected because it contains a preservative and is designed for multiple entries under aseptic handling. The preservative is usually benzyl alcohol at 0.9%. (DailyMed)

Sterile water does not contain a preservative. This means it may be suitable for short, single-session laboratory preparation, but it is not ideal when the vial will be accessed repeatedly.

That said, bacteriostatic water is not automatically the right choice for every assay. Some research protocols may require a specific buffer, pH range, or solvent system.

Peptide solubility depends on sequence, polarity, charge, and the assay environment, so the supplier’s documentation should always be checked before preparation.

Bachem notes that peptide solubility can vary significantly and that there is no single universal dissolving protocol for all peptides.

For most straightforward BPC-157 research preparations, bacteriostatic water is commonly used because it is simple, sterile, and easier to manage when repeated laboratory withdrawals are expected.

How To Reconstitute BPC-157: Step-By-Step Guide

Step 1: Let the vial reach room temperature

Remove the BPC-157 vial from cold storage and allow it to sit unopened until it reaches room temperature.

This helps reduce condensation. Opening a cold vial too quickly can allow moisture from the air to enter, which is not ideal for lyophilised peptides.

It is recommended to warm peptide vials to room temperature before opening as part of standard peptide handling.

Do not open the vial while it is still cold.

Step 2: Clean the workspace

Use a clean, flat surface. Wipe the area before placing the vial and supplies down.

Then clean the rubber tops of both vials with alcohol swabs. Let them air-dry for a few seconds before continuing.

This step is simple, but it matters. Reconstitution involves repeated contact with vial stoppers, so keeping the workspace clean reduces contamination risk.

Step 3: Decide the final concentration

Before adding any liquid, decide on the concentration you want to create.

The basic formula is:

Peptide amount ÷ liquid volume = final concentration

For example:

5 mg BPC-157 ÷ 2 ml liquid = 2.5 mg/ml

That means every 1 ml of solution contains 2.5 mg of BPC-157.

Choose the liquid volume based on the research protocol, required concentration, and measurement accuracy.

You can use XL Peptide Calculator for more information.

BPC-157 Concentration Reference Table

For a 5 mg BPC-157 vial:

Liquid Added

Final Concentration

1 ml

5 mg/ml

2 ml

2.5 mg/ml

3 ml

1.67 mg/ml

5 ml

1 mg/ml

For a 10 mg BPC-157 vial

10 mg/ml

4 ml

2 mg/ml

10 ml

For most lab workflows, it is better to choose a concentration that is easy to calculate later. Round numbers reduce measurement errors.

Step 4: Draw the chosen amount of liquid

Measure the selected volume of bacteriostatic

water or chosen sterile diluent.

Use a sterile measuring syringe or calibrated micropipette. For best accuracy, read the measurement at eye level and avoid air bubbles.

If air bubbles are present, remove them before transferring the liquid into the peptide vial. Air pockets can affect measurement accuracy, especially when working with small volumes.

Step 5: Add the liquid slowly down the inside wall

Transfer the liquid slowly into the BPC-157 vial.

Do not aim the stream directly at the powder cake. Instead, angle the liquid so it runs gently down the inside wall of the vial.

This helps protect the lyophilised material from unnecessary force and reduces foaming.

Gentle handling is especially useful with peptides because some can take time to dissolve fully.

Step 6: Let the vial sit briefly

After adding the liquid, let the vial sit undisturbed for a short time. This gives the powder a chance to hydrate before mixing.

Some lyophilised material begins dissolving almost immediately, while some may cling to the glass or form small, soft clumps at first.

Do not rush this step.

Step 7: Gently swirl, do not shake

Hold the vial between your fingers and gently rotate or swirl it.

Do not shake aggressively.

Shaking can create foam and bubbles, making it harder to inspect the solution. It can also make the vial appear cloudy even when the peptide is still dissolving.

Continue gentle swirling until the solution looks clear or evenly dissolved.

Peptide reconstitution can sometimes take time and may require patience depending on peptide properties.

Step 8: Inspect the solution

Once mixed, check the vial carefully.

A properly prepared BPC-157 solution should usually appear clear or nearly clear. It should not contain visible particles, unexpected floating material, or unusual discolouration.

Do not continue with research work if the solution has:

Visible fibres or particles

Strong cloudiness that does not settle

Yellow, brown, or unusual colour change

Contamination signs around the stopper

Cracked vial glass or damaged seal

DailyMed guidance for reconstituted materials also highlights visual inspection for clarity, unexpected precipitation, and discolouration.

Step 9: Label the vial

Label the vial immediately after preparation.

Include:

Peptide name

Starting amount

Liquid volume added

Final concentration

Reconstitution date

Storage condition

BPC-157 | 5 mg + 2 ml BAC water | 2.5 mg/ml | Prepared: [date] | Store 2–8°C

This avoids confusion later, especially if multiple research vials are stored together.

How to Calculate Any BPC-157 Concentration

You may use our peptide calculator or use this formula:

Final concentration = peptide amount ÷ liquid volume

Example:

10 mg ÷ 4 ml = 2.5 mg/ml

To calculate the volume needed for a specific research measurement:

Required peptide amount ÷ concentration = liquid volume

If the solution is 2.5 mg/ml and the required research amount is 0.25 mg:

0.25 mg ÷ 2.5 mg/ml = 0.1 ml

This is why concentration planning matters. A simple concentration makes the rest of the research workflow easier.

Storage After BPC-157 Reconstitution

Lyophilised peptides are generally more stable than peptide solutions.

These peptides are commonly stored at -20°C and protected from light, while peptide solutions have a shorter shelf life and are more vulnerable to bacterial degradation.

It is also advised that peptides should generally be kept as lyophilised material for longer storage, while prepared solutions are better divided into aliquots and frozen if storage is necessary, per Bachem.

For BPC-157 research preparation, a practical storage approach is:

State

Suggested Storage

Lyophilised, unopened vial

Cold, dry, dark storage; often -20°C for longer-term storage

Reconstituted solution

Refrigerated at 2–8°C unless protocol states otherwise

Prepared aliquots

Store according to protocol; avoid repeated freeze-thaw cycles

Damaged, cloudy, or contaminated solution

Do not use for research work

Avoid repeated warming and cooling. Repeated temperature changes can reduce consistency and may affect peptide integrity over time.

Troubleshooting: Common Reconstitution Problems

The powder is not dissolving

Let the vial sit for longer, then continue gentle swirling.

Some lyophilised peptide cakes dissolve quickly, while others need more time. Do not shake the vial to force the process.

If particles remain after a reasonable waiting period, check the supplier documentation and confirm that the selected diluent is suitable.

The solution looks cloudy

Cloudiness can happen for several reasons.

It may be temporary foaming from movement, incomplete dissolution, or incompatibility with the selected liquid. Let the vial rest and inspect again.

If cloudiness remains, do not assume the solution is suitable. A research solution should be clear or nearly clear unless the protocol specifically says otherwise.

The solution has changed colour

Unexpected colour change is a warning sign.

BPC-157 solution should not become strongly yellow, brown, or visibly discoloured. This may suggest contamination, degradation, or poor storage conditions.

Do not continue using a visibly discoloured vial for research work.

Too much liquid was added

This does not necessarily ruin the vial, but it changes the concentration.

Recalculate the concentration using the new total liquid volume.

If a 5 mg vial was intended to be mixed with 2 ml, but 3 ml was added:

5 mg ÷ 3 ml = 1.67 mg/ml

Update the label immediately so the vial does not get used with the wrong concentration later.

The vial was shaken by mistake

Let the vial sit until bubbles and foam settle.

Then inspect for clarity, floating particles, and colour change. If the solution becomes clear after resting, the main issue may simply have been trapped air.

If it remains cloudy or contains visible particles, do not use it for controlled research work.

Note: This article is for educational and research information only. Products discussed are intended for laboratory research use only and are not for clinical, food, cosmetic, veterinary, or household applications.

Frequently Asked Questions

What is the best liquid for BPC-157 reconstitution?

Bacteriostatic water is commonly used for research peptide reconstitution because it is sterile and contains benzyl alcohol as a preservative.

How much bacteriostatic water should be added to BPC-157?

It depends on the concentration required. For example, adding 2 ml to a 5 mg vial creates a 2.5 mg/ml solution. Adding 1 ml to the same vial creates a 5 mg/ml solution.

Should BPC-157 be shaken after adding liquid?

No. Gentle swirling is preferred. Shaking can create foam and make the solution harder to inspect.

What should reconstituted BPC-157 look like?

It should usually look clear or nearly clear, with no visible particles or unusual colour change.

Can BPC-157 be stored as a solution long-term?

Peptides are generally more stable as lyophilised powders than as solutions. Prepared peptide solutions have a shorter usable window and should be stored according to the protocol and supplier guidance.

Why does the vial need to be labelled?

Labelling prevents concentration errors. Always include the peptide name, starting amount, liquid volume, final concentration, preparation date, and storage condition.

Final Words

BPC-157 reconstitution is a simple process, but accuracy matters.

The key points are to calculate the concentration before starting, add the liquid slowly, swirl gently, inspect the final solution, and label the vial clearly.

For research work, consistency is everything. A clean process and accurate concentration record make the prepared solution easier to manage across the full protocol.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Developing a Research Protocol: Dosage and Administration for the BPC-157 Beginners Guide

Formulating a sound research protocol is arguably the most critical step after securing high-quality peptides. For any BPC-157 beginners guide, discussions around dosage and administration are front and center. It's not a one-size-fits-all scenario; rather, it's a carefully considered process informed by existing literature, the specific animal model, and the research objectives. Dosage Considerations: Preclinical studies have explored a wide range of dosages for BPC-157, often expressed in micrograms per kilogram (µg/kg) of body weight. It's vital to meticulously review existing research to establish a starting point. We've found that researchers often begin with lower doses and gradually adjust based on observations and safety profiles within their specific experimental setup. Remember, the goal is to find the optimal dose that elicits the desired effect without introducing undue variables. This iterative process is a cornerstone of responsible research, and a key takeaway from any effective BPC-157 beginners guide. Administration Frequency and Duration: Just as important as the dose is how often and for how long the peptide is administered. Many studies utilize daily administration, sometimes split into two doses, for durations ranging from a few days to several weeks, depending on the tissue being studied and the regenerative timeline. For instance, tendon healing might require a longer duration than, say, acute gastric protection. Our recommendation: create a detailed s…
STORAGE

Temperature: The Arch-Nemesis of Peptide Stability

We can't stress this enough: temperature is the single most significant factor influencing the rate of BPC-157 degradation reconstituted. It’s the accelerator pedal for nearly every degradation pathway we just mentioned. Think of it this way: chemical reactions, including the ones that break down peptides, happen faster at higher temperatures. Room temperature might feel comfortable to you, but for a reconstituted peptide, it's a hostile environment. Leaving a vial on a lab bench for even a few hours can initiate a cascade of degradation that is completely irreversible. We've seen data showing that some peptides can lose over 50% of their potency within 24 hours at room temperature. That's a catastrophic loss. The entire issue of BPC-157 degradation reconstituted is, in many ways, a battle against thermal energy. This is non-negotiable. Once reconstituted, BPC-157 must be stored in a refrigerator, typically between 2°C and 8°C (36°F and 46°F). This cold environment dramatically slows down molecular motion and the chemical reactions responsible for BPC-157 degradation reconstituted. It doesn't stop them entirely—degradation is an inevitable process—but it slows them to a crawl, preserving the peptide's integrity for weeks instead of hours. Consistently managing temperature is the most powerful tool you have to combat BPC-157 degradation reconstituted and ensure the compound you're studying today is the same as the one you study next week.
02

Question drills

Open a question for its connected answer.

01What If I'm Using BPC-157 Capsules Instead of Injectable—Do I Still Need Syringes?+

No. BPC-157 Capsules eliminate injection supplies entirely, but understand the bioavailability trade-off: oral BPC-157 undergoes first-pass hepatic metabolism and gastric protease degradation that reduces systemic absorption to 5-15% of the ingested dose compared to 85-95% for subcutaneous injection. Capsules work for localized gastric and intestinal applications where the peptide acts on mucosal tissue before absorption, but they're not equivalent to injection for systemic research applications. If your protocol targets connective tissue repair or systemic anti-inflammatory pathways, injectable BPC-157 with proper syringe supplies remains the evidence-based choice.

SOURCE / realpeptides.co ↗
02What If BPC-157 Acts Through Multiple Low-Affinity Targets Rather Than One High-Affinity Receptor?+

This is the leading hypothesis among researchers who study BPC-157 receptor pharmacology. If BPC-157 binds weakly to several different signaling proteins. Rather than strongly to one receptor. It would explain the peptide's broad tissue effects and resistance to single-pathway inhibition. You'd see overlapping downstream activation (VEGF, NO, FAK) because each weak interaction contributes partial signaling. Testing this requires binding studies at multiple candidate targets simultaneously, not sequential receptor screens, and demands higher peptide concentrations than standard radioligand displacement assays use.

SOURCE / realpeptides.co ↗
03What If the Peptide Loses Activity During Storage or Handling?+

Store lyophilized BPC-157 at −20°C before reconstitution; once mixed with bacteriostatic water, refrigerate at 2–8°C and use within 28 days. BPC-157 animal research protocols typically prepare fresh solutions every 7–14 days, and studies document activity loss when peptides are exposed to repeated freeze-thaw cycles or stored at room temperature beyond 24 hours. Temperature excursions above 25°C for extended periods likely denature the peptide structure, rendering it inactive—visual inspection cannot detect this.

SOURCE / realpeptides.co ↗
04What If I’m Researching BPC-157 for Injury Recovery in Denver — What Else Should I Consider?+

Denver’s high altitude and active population make dehydration and inflammation common variables in injury recovery research. Researchers often combine BPC-157 with adequate hydration protocols and anti-inflammatory support peptides like TB-500. Real Peptides offers pre-configured recovery stacks that pair BPC-157 with complementary peptides, saving 15% versus individual purchases and ensuring compatible reconstitution protocols. All stacks ship together to Denver addresses with unified dosing guidance and COA documentation.

SOURCE / realpeptides.co ↗
05What If My Reconstituted Solution Looks Cloudy?+

Cloudiness after gentle swirling indicates incomplete dissolution or peptide aggregation—do not inject. Refrigerate the vial for 15–20 minutes, then swirl again gently. If clarity doesn't improve, the batch may have been exposed to temperature excursion during shipping or storage, causing irreversible protein denaturation. Lyophilised BPC-157 stored above 25°C for more than 48 hours shows measurable aggregation in spectroscopic analysis—once aggregated, the peptide cannot be 'fixed' by additional mixing time.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

BPC-157 Reconstitution for In Vitro Research: Laboratory Preparation Guide

BPC-157 Reconstitution for In Vitro Research: Laboratory Preparation Guide BPC-157 Reconstitution for In Vitro Research: Laboratory Preparation Guide Body Protective Compound-157 represents a pentadecapeptide sequence derived from human gastric juice research, exhibiting unique structural properties that make it valuable for in vitro cellular studies. This synthetic peptide fragment has garnered significant attention in laboratory settings for investigating cellular protection mechanisms, angiogenic pathways, and tissue repair processes at the molecular level. The lyophilized formulation ensures optimal stability during storage and transport, requiring proper reconstitution techniques to maintain peptide integrity for reliable experimental outcomes. Required Laboratory Materials BPC-157 5mg lyophilized vial (Element SARMs) Sterile bacteriostatic water or appropriate research-grade solvent Precision micropipettes (1-1000μL range) Sterile filtered pipette tips Laminar flow hood or biosafety cabinet 70% isopropanol for surface decontamination Sterile laboratory vortex mixer Refrigerated centrifuge (optional for clarification) Amber glass storage vials or appropriate containers Laboratory notebook for documentation Analytical balance (0.1mg precision minimum) Pre-Reconstitution Laboratory Preparation Establish aseptic working conditions within a laminar flow hood, ensuring all surfaces undergo thorough decontamination with 70% isopropanol. Allow the BPC-157 vial to equilibrate to room temperature for approximately 15-20 minutes before handling to prevent condensation formation during reconstitution. Verify solvent selection based on intended experimental parameters, with bacteriostatic water being suitable for most in vitro applications. Calculate the required final concentration based on experimental design requirements, ensuring adequate volume for multiple assays if necessary. Solvent Considerations for Optimal Reconstitution Bacteriostatic water provides excellent stability for BPC-157 while maintaining peptide structural integrity. Alternative solvents such as phosphate-buffered saline may be considered for specific experimental protocols requiring physiological ionic strength. Avoid solvents containing organic components that may interfere with peptide folding or experimental readouts. Temperature of the reconstitution solvent should be maintained between 2-8°C to minimize degradation during the mixing process. Step-by-Step Reconstitution Protocol Step 1: Remove the protective cap from the BPC-157 vial and sanitize the rubber stopper with 70% isopropanol, allowing complete evaporation before proceeding. Step 2: Using a precision micropipette with sterile tip, slowly draw the calculated volume of reconstitution solvent, ensuring no air bubbles are present in the pipette tip. Step 3: Insert the pipette tip through the rubber stopper at a 45-degree angle, directing the solvent stream toward the vial wall rather than directly onto the lyophilized powder to prevent foaming. Step 4: Dispense the solvent slowly and steadily, maintaining contact between the pipette tip and vial wall throughout the addition process. Step 5: Remove the pipette tip and gently swirl the vial in a circular motion for 30-45 seconds to initiate dissolution without creating excessive agitation. Step 6: Allow the solution to stand for 2-3 minutes at room temperature to complete dissolution, observing for complete clarity and absence of particulate matter. Step 7: If needed, apply gentle vortex mixing at low speed for 10-15 seconds to ensure homogeneous distribution throughout the solution. Concentration Options and Volume Calculations 1.0 mL 5.0 mg/mL High-concentration stock solutions 2.0 mL 2.5 mg/mL Standard laboratory preparations 5.0 mL 1.0 mg/mL Multiple assay applications Storage Conditions and Stability Store reconstituted BPC-157 solutions at 2-8°C in amber glass containers to protect from light exposure and maintain peptide stability. Aliquot larger volumes into smaller working portions to minimize freeze-thaw cycles and contamination risk. Under proper refrigerated storage conditions, reconstituted solutions maintain stability for 4-6 weeks when handled using aseptic technique. For extended storage beyond this timeframe, consider freezing aliquots at -20°C or -80°C, though this may require validation of post-thaw activity for specific experimental applications. Research Application Notes Element SARMs' BPC-157 formulation provides researchers with consistent peptide quality for investigating cellular protection mechanisms and regenerative processes. The reconstituted peptide solution serves as an excellent starting material for dose-response studies, time-course experiments, and mechanistic investigations in various cell culture systems. Researchers should validate peptide concentration through appropriate analytical methods and consider the experimental pH range when planning buffer compatibility studies. All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition. Hexarelin TB-500 Epithalon Ipamorelin Tirzepatide CJC-1295 DAC PT-141 Semaglutide Selank BPC-157 Sermorelin Melanotan 2 IGF LR3 Tesamorelin AICAR IGF-DES GHRP 2 Albuterol Tamoxifen Letrozole Clomiphene Tadalafil Clenbuterol Anastrozole Finasteride Exemestane Sildenafil Yohimbine Bacteriostatic Water Recent Posts Melanotan 2 (MT2): Mechanism, Research, and Safety Considerations Ipamorelin: The Selective GHRP, Explained Tesamorelin: The GHRH Analog Studied for Visceral Fat Sermorelin: The Original GHRH Analog, Explained CJC-1295: How the GHRH Analog Works, and What Research Shows Already a customer? Sign In Create Account All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act. Sarms Stacks Research Liquids Albuterol 5MG/ML | 30ML with dropper Anastrozole 1.5MG/ML | 30ML with dropper Clomiphene 50MG/ML | 30ML with dropper Finasteride 5MG/ML | 30ML with dropper Letrozole 3.5 MG/ML | 30ML with dropper LiquiCia 30MG/ML | 30ML with dropper LiquiCia T50 50MG/ML | 30ML with dropper LiquiClen 200MCG/ML | 30ML with dropper Liquistane / Exemestane 25MG/ML | 30ML with dropper LiquiTamo 20MG/ML | 30ML with dropper LiquiVia 25MG/ML | 30 ML with dropper T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper Toremifene Citrate 60MG/ML | 30ML with dropper Yohimbine HCL 10MG/ML | 30ML with dropper Research Peptides Aicar 50MG BPC-157 + TB-500 Blend 2mg ea/ 4MG BPC-157 5MG CJC-1295 + DAC 2MG CJC-1295 | No DAC 2MG Epithalon 10MG Frag Premium 176-191 5MG GHK-CU Copper Peptide 50MG GHRP-2 5MG GHRP-6 5MG Hexarelin 5MG IGF-1 DES 1MG IGF-1 LR3 1MG Ipamorelin 5MG Melanotan 2 10MG NAD+ 500MG PT-141 / Bremelanotide 10MG GLP-1/GIP/GCG (RT) Selank 5MG GLP1 (SM) Sermorelin 5MG TB-500 5MG GIP/GLP-1 (TZ) PDE5 Inhibitors GLP-1 Diluents Bacteriostatic Water 10ML

RESEARCH

Related Research

Reconstitution Protocols for BPC-157 and TB-500 Research Peptides: Lab Best Practices Bacteriostatic Water (BAC Water) Complete Guide: What It Is and Why It Matters in Peptide Research What Is BPC-157? A Complete Research Introduction

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

BPC-157 ARA-290 for Neuropathy Research: Study Design Comparison

BPC-157 VEGF upregulation, angiogenesis, endothelial repair Sciatic nerve crush models (rats). Functional recovery at 10 μg/kg IP No completed human neuropathy trials Subcutaneous…

Comparison

BPC-157 + LL-37 Stack: Research Protocol Comparison

Primary Mechanism VEGF upregulation, immune modulation, tissue repair signalling Direct bacterial membrane disruption, endotoxin neutralisation, immune cell recruitment Dual-pathw…